Remdesivir Archives

Permanente Medicine powers coordinated effort around remdesivir clinical research trials

May 21, 2020

Collaboration between Kaiser Permanente’s care delivery system and research programs has driven the successful implementation of remdesivir clinical trials across regions.

Initial COVID-19 drug trials ‘give us hope,’ Stephen Parodi, MD, tells CBSN

May 11, 2020

Stephen Parodi, MD, associate executive director of The Permanente Medical Group and national infectious disease leader for Kaiser Permanente, spoke with CBSN recently about why trials with remdesivir and other drugs matter. CBSN is the CBS News 24/7 digital streaming service.

Kaiser Permanente research centers prioritize urgent COVID-19 research projects, clinical trials

May 2, 2020

In an effort to improve understanding and clinical practice guidelines around the novel coronavirus, Kaiser Permanente’s various research centers are quickly moving to investigate potential treatment for COVID-19.